Inovio Pharmaceuticals
INO
#8782
Rank
NZ$0.27 B
Marketcap
NZ$3.96
Share price
0.58%
Change (1 day)
24.94%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.97. In 2024 the company made an earnings per share (EPS) of NZ-$6.82 an increase over its 2023 EPS that were of NZ-$10.51.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-29.52%
2024NZ-$6.82-35.14%
2023NZ-$10.51-56.62%
2022NZ-$24.23-19.54%
2021NZ-$30.1135.9%
2020NZ-$22.16-11.57%
2019NZ-$25.0615.24%
2018NZ-$21.74-2.78%
2017NZ-$22.366.93%
2016NZ-$20.91134.88%
2015NZ-$8.90-29.51%
2014NZ-$12.63-57.34%
2013NZ-$29.61146.55%
2012NZ-$12.0120.83%
2011NZ-$9.94-29.41%
2010NZ-$14.08-48.48%
2009NZ-$27.3310%
2008NZ-$24.8511.11%
2007NZ-$22.36-41.3%
2006NZ-$38.10-66.91%
2005NZ-$115.13110.61%
2004NZ-$54.67-61.63%
2003NZ-$142.47186.67%
2002NZ-$49.70
2001N/A-100%
2000NZ-$39.76-63.64%
1999NZ-$109.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.97-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.01-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$2.16-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.70-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.10-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.21-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.25-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA